Experiences and Perceptions of Patients and Providers Participating in Remote Titration of Heart Failure Medication Facilitated by Telemonitoring: Qualitative Study

Veronica Artanian, Patrick Ware, Valeria E Rac, Heather J Ross, Emily Seto, Veronica Artanian, Patrick Ware, Valeria E Rac, Heather J Ross, Emily Seto

Abstract

Background: Guideline-directed medical therapy (GDMT), optimized to target doses, improves health outcomes in patients with heart failure. However, GDMT remains underused, with <25% of patients receiving target doses in clinical practice. A randomized controlled trial was conducted at the Peter Munk Cardiac Centre in Toronto to compare a remote GDMT titration intervention with standard in-office titration. This randomized controlled trial found that remote titration increased the proportion of patients who achieved optimal GDMT doses, decreased the time to dose optimization, and reduced the number of essential clinic visits. This paper presents findings from the qualitative component of the mixed methods study, which evaluated the implementation of the remote titration intervention.

Objective: The objective of the qualitative component is to assess the perceptions and experiences of clinicians and patients with heart failure who participated in the remote titration intervention to identify factors that affected the implementation of the intervention.

Methods: We conducted semistructured interviews with clinicians (n=5) and patients (n=11) who participated in the remote titration intervention. Questions probed the experiences of the participants to identify factors that can serve as barriers and facilitators to its implementation. Conventional content analysis was first used to analyze the interviews and gain direct information based on the participants' unique perspectives. Subsequently, the generated themes were delineated and mapped following a multilevel framework.

Results: Patients and clinicians indicated that the intervention was easy to use, integrated well into their routines, and removed practical barriers to titration. Key implementation facilitators from the patients' perspective included the reduction in clinic visits and daily monitoring of their condition, whereas clinicians emphasized the benefits of rapid drug titration and efficient patient management. Key implementation barriers included the resources necessary to support the intervention and lack of physician remuneration.

Conclusions: This study presents results from a real-world implementation assessment of remote titration facilitated by telemonitoring. It is among the first to provide insight into the perception of the remote titration process by clinicians and patients. Our findings indicate that the relative advantages that remote titration presents over standard care strongly appeal to both clinicians and patients. However, to ensure uptake and adherence, it is important to ensure that suitable patients are enrolled and the impact on the physicians' workload is minimized. The implementation of remote titration is now more critical than ever, as it can help provide access to care for patients during times when physical distancing is required.

Trial registration: ClinicalTrials.gov NCT04205513; https://ichgcp.net/clinical-trials-registry/NCT04205513.

International registered report identifier (irrid): RR2-10.2196/19705.

Keywords: heart failure; mHealth; mobile phone; monitoring; qualitative; remote; telemonitoring; titration.

Conflict of interest statement

Conflicts of Interest: Members of the research team (ES and HJR) have intellectual property rights of the Medly system.

©Veronica Artanian, Patrick Ware, Valeria E Rac, Heather J Ross, Emily Seto. Originally published in JMIR Cardio (https://cardio.jmir.org), 25.11.2021.

References

    1. Roger VL. Epidemiology of heart failure. Circ Res. 2013 Aug 30;113(6):646–59. doi: 10.1161/circresaha.113.300268.
    1. Atherton JJ, Hickey A. Expert comment: is medication titration in heart failure too complex? Card Fail Rev. 2017;3(1):25–32. doi: 10.15420/cfr.2017:1:2.
    1. Maggioni AP, Anker SD, Dahlström U, Filippatos G, Ponikowski P, Zannad F, Amir O, Chioncel O, Leiro MC, Drozdz J, Erglis A, Fazlibegovic E, Fonseca C, Fruhwald F, Gatzov P, Goncalvesova E, Hassanein M, Hradec J, Kavoliuniene A, Lainscak M, Logeart D, Merkely B, Metra M, Persson H, Seferovic P, Temizhan A, Tousoulis D, Tavazzi L, Heart Failure Association of the ESC Are hospitalized or ambulatory patients with heart failure treated in accordance with European Society of Cardiology guidelines? Evidence from 12,440 patients of the ESC Heart Failure Long-Term Registry. Eur J Heart Fail. 2013 Oct 27;15(10):1173–84. doi: 10.1093/eurjhf/hft134. doi: 10.1093/eurjhf/hft134.hft134
    1. Greene SJ, Butler J, Albert NM, DeVore AD, Sharma PP, Duffy CI, Hill CL, McCague K, Mi X, Patterson JH, Spertus JA, Thomas L, Williams FB, Hernandez AF, Fonarow GC. Medical therapy for heart failure with reduced ejection fraction: the CHAMP-HF Registry. J Am Coll Cardiol. 2018 Jul 24;72(4):351–66. doi: 10.1016/j.jacc.2018.04.070.S0735-1097(18)34906-4
    1. Gracia E, Hamid A, Butler J. Timely management of new-onset heart failure. Circulation. 2019 Aug 20;140(8):621–3. doi: 10.1161/circulationaha.118.035452.
    1. Zaman S, Zaman SS, Scholtes T, Shun-Shin MJ, Plymen CM, Francis DP, Cole GD. The mortality risk of deferring optimal medical therapy in heart failure: a systematic comparison against norms for surgical consent and patient information leaflets. Eur J Heart Fail. 2017 Nov 08;19(11):1401–9. doi: 10.1002/ejhf.838. doi: 10.1002/ejhf.838.
    1. Clark RA, Inglis SC, McAlister FA, Cleland JG, Stewart S. Telemonitoring or structured telephone support programmes for patients with chronic heart failure: systematic review and meta-analysis. Br Med J. 2007 May 05;334(7600):942. doi: 10.1136/bmj.39156.536968.55. bmj.39156.536968.55
    1. Kotb A, Cameron C, Hsieh S, Wells G. Comparative effectiveness of different forms of telemedicine for individuals with heart failure (HF): a systematic review and network meta-analysis. PLoS One. 2015 Feb 25;10(2):e0118681. doi: 10.1371/journal.pone.0118681. PONE-D-14-23064
    1. Zhu Y, Gu X, Xu C. Effectiveness of telemedicine systems for adults with heart failure: a meta-analysis of randomized controlled trials. Heart Fail Rev. 2020 Mar 24;25(2):231–43. doi: 10.1007/s10741-019-09801-5. 10.1007/s10741-019-09801-5
    1. Seto E, Leonard KJ, Masino C, Cafazzo JA, Barnsley J, Ross HJ. Attitudes of heart failure patients and health care providers towards mobile phone-based remote monitoring. J Med Internet Res. 2010 Nov 29;12(4):e55. doi: 10.2196/jmir.1627. v12i4e55
    1. Fairbrother P, Ure J, Hanley J, McCloughan L, Denvir M, Sheikh A, McKinstry B, Telescot Programme Team Telemonitoring for chronic heart failure: the views of patients and healthcare professionals - a qualitative study. J Clin Nurs. 2014 Jan 04;23(1-2):132–44. doi: 10.1111/jocn.12137.
    1. Hunting G, Shahid N, Sahakyan Y, Fan I, Moneypenny CR, Stanimirovic A, North T, Petrosyan Y, Krahn MD, Rac VE. A multi-level qualitative analysis of Telehomecare in Ontario: challenges and opportunities. BMC Health Serv Res. 2015 Dec 09;15(1):544. doi: 10.1186/s12913-015-1196-2. 10.1186/s12913-015-1196-2
    1. D'Onofrio A, Palmisano P, Rapacciuolo A, Ammendola E, Calò L, Ruocco A, Bianchi V, Maresca F, Del Giorno G, Martino A, Mauro C, Campari M, Valsecchi S, Accogli M. Effectiveness of a management program for outpatient clinic or remote titration of beta-blockers in CRT patients: the RESTORE study. Int J Cardiol. 2017 Jun 01;236:290–5. doi: 10.1016/j.ijcard.2017.02.015.S0167-5273(16)34678-2
    1. Smeets CJ, Storms V, Vandervoort PM, Dreesen P, Vranken J, Houbrechts M, Goris H, Grieten L, Dendale P. A novel intelligent two-way communication system for remote heart failure medication uptitration (the CardioCoach study): randomized controlled feasibility trial. JMIR Cardio. 2018 Apr 04;2(1):e8. doi: 10.2196/cardio.9153. v2i1e8
    1. Steckler A, Bishu K, Wassif H, Sigurdsson G, Wagner J, Jaenicke C, Vats S, Rector T, Anand IS. Telephone titration of heart failure medications. J Cardiovasc Nurs. 2011;26(1):29–36. doi: 10.1097/JCN.0b013e3181ec1223.
    1. Moyer-Knox D, Mueller TM, Vuckovic K, Mischke L, Williams RE. Remote titration of carvedilol for heart failure patients by advanced practice nurses. J Card Fail. 2004 Jun;10(3):219–24. doi: 10.1016/j.cardfail.2003.09.009.S1071916403007188
    1. Spaeder J, Najjar SS, Gerstenblith G, Hefter G, Kern L, Palmer JG, Gottlieb SH, Kasper EK. Rapid titration of carvedilol in patients with congestive heart failure: a randomized trial of automated telemedicine versus frequent outpatient clinic visits. Am Heart J. 2006 Apr;151(4):1–10. doi: 10.1016/j.ahj.2005.06.044.S0002-8703(05)00658-7
    1. Artanian V, Ross HJ, Rac VE, O'Sullivan M, Brahmbhatt DH, Seto E. Impact of remote titration combined with telemonitoring on the optimization of guideline-directed medical therapy for patients with heart failure: internal pilot of a randomized controlled trial. JMIR Cardio. 2020 Nov 03;4(1):e21962. doi: 10.2196/21962. v4i1e21962
    1. Artanian V, Rac VE, Ross HJ, Seto E. Impact of remote titration combined with telemonitoring on the optimization of guideline-directed medical therapy for patients with heart failure: protocol for a randomized controlled trial. JMIR Res Protoc. 2020 Oct 13;9(10):e19705. doi: 10.2196/19705. v9i10e19705
    1. Seto E, Leonard KJ, Cafazzo JA, Barnsley J, Masino C, Ross HJ. Mobile phone-based telemonitoring for heart failure management: a randomized controlled trial. J Med Internet Res. 2012 Feb 16;14(1):e31. doi: 10.2196/jmir.1909. v14i1e31
    1. Ware P, Ross HJ, Cafazzo JA, Laporte A, Gordon K, Seto E. Evaluating the implementation of a mobile phone-based telemonitoring program: longitudinal study guided by the consolidated framework for implementation research. JMIR Mhealth Uhealth. 2018 Jul 31;6(7):e10768. doi: 10.2196/10768. v6i7e10768
    1. Ware P, Ross HJ, Cafazzo JA, Boodoo C, Munnery M, Seto E. Outcomes of a heart failure telemonitoring program implemented as the standard of care in an outpatient heart function clinic: pretest-posttest pragmatic study. J Med Internet Res. 2020 Feb 08;22(2):e16538. doi: 10.2196/16538. v22i2e16538
    1. Palinkas LA, Horwitz SM, Green CA, Wisdom JP, Duan N, Hoagwood K. Purposeful sampling for qualitative data collection and analysis in mixed method implementation research. Adm Policy Ment Health. 2015 Sep 6;42(5):533–44. doi: 10.1007/s10488-013-0528-y.
    1. Chaudoir SR, Dugan AG, Barr CH. Measuring factors affecting implementation of health innovations: a systematic review of structural, organizational, provider, patient, and innovation level measures. Implement Sci. 2013 Feb 17;8(6):22. doi: 10.1186/1748-5908-8-22. 1748-5908-8-22
    1. Hsieh H, Shannon SE. Three approaches to qualitative content analysis. Qual Health Res. 2005 Nov 01;15(9):1277–88. doi: 10.1177/1049732305276687.15/9/1277
    1. Proctor E, Silmere H, Raghavan R, Hovmand P, Aarons G, Bunger A, Griffey R, Hensley M. Outcomes for implementation research: conceptual distinctions, measurement challenges, and research agenda. Adm Policy Ment Health. 2011 Mar 19;38(2):65–76. doi: 10.1007/s10488-010-0319-7.
    1. Cohen S, Halvorson H, Gosselink C. Changing physician behavior to improve disease prevention. Prev Med. 1994 May;23(3):284–91. doi: 10.1006/pmed.1994.1040.S0091-7435(84)71040-1
    1. Prochaska JO, DiClemente CC. Stages and processes of self-change of smoking: toward an integrative model of change. J Consult Clin Psychol. 1983;51(3):390–5. doi: 10.1037/0022-006x.51.3.390.
    1. Klein KJ, Sorra JS. The challenge of innovation implementation. Acad Manag Rev. 1996 Oct;21(4):1055–80. doi: 10.5465/amr.1996.9704071863.
    1. Glasgow RE, Vogt TM, Boles SM. Evaluating the public health impact of health promotion interventions: the RE-AIM framework. Am J Public Health. 1999 Sep;89(9):1322–7. doi: 10.2105/ajph.89.9.1322.
    1. Proctor EK, Landsverk J, Aarons G, Chambers D, Glisson C, Mittman B. Implementation research in mental health services: an emerging science with conceptual, methodological, and training challenges. Adm Policy Ment Health. 2009 Jan 23;36(1):24–34. doi: 10.1007/s10488-008-0197-4.
    1. Rogers EM. Diffusion of Innovations, 5th Ed. New York: Free Press; 2003.
    1. Durlak J, DuPre E. Implementation matters: a review of research on the influence of implementation on program outcomes and the factors affecting implementation. Am J Community Psychol. 2008 Jun;41(3-4):327–50. doi: 10.1007/s10464-008-9165-0.
    1. Damschroder LJ, Aron DC, Keith RE, Kirsh SR, Alexander JA, Lowery JC. Fostering implementation of health services research findings into practice: a consolidated framework for advancing implementation science. Implement Sci. 2009 Aug 07;4(1):50. doi: 10.1186/1748-5908-4-50. 1748-5908-4-50
    1. Turner J, Brown JC, Carpenter DT. Telephone-based CBT and the therapeutic relationship: the views and experiences of IAPT practitioners in a low-intensity service. J Psychiatr Ment Health Nurs. 2018 Jun 30;25(5-6):285–96. doi: 10.1111/jpm.12440.
    1. Turgoose D, Ashwick R, Murphy D. Systematic review of lessons learned from delivering tele-therapy to veterans with post-traumatic stress disorder. J Telemed Telecare. 2017 Sep 29;24(9):575–85. doi: 10.1177/1357633x17730443.
    1. Desai AS, Stevenson LW. Connecting the circle from home to heart-failure disease management. N Engl J Med. 2010 Dec 09;363(24):2364–7. doi: 10.1056/nejme1011769.
    1. de Vries AE, van der Wal MH, Nieuwenhuis MM, de Jong RM, van Dijk RB, Jaarsma T, Hillege HL. Health professionals' expectations versus experiences of internet-based telemonitoring: survey among heart failure clinics. J Med Internet Res. 2013 Jan 10;15(1):e4. doi: 10.2196/jmir.2161. v15i1e4
    1. Kato NP, Johansson P, Okada I, de Vries AE, Kinugawa K, Strömberg A, Jaarsma T. Heart failure telemonitoring in Japan and Sweden: a cross-sectional survey. J Med Internet Res. 2015 Nov 13;17(11):e258. doi: 10.2196/jmir.4825. v17i11e258
    1. Papoutsi C, A'Court C, Wherton J, Shaw S, Greenhalgh T. Explaining the mixed findings of a randomised controlled trial of telehealth with centralised remote support for heart failure: multi-site qualitative study using the NASSS framework. Trials. 2020 Oct 27;21(1):891. doi: 10.1186/s13063-020-04817-x. 10.1186/s13063-020-04817-x
    1. Boyne JJ, Vrijhoef HJ. Implementing telemonitoring in heart failure care: barriers from the perspectives of patients, healthcare professionals and healthcare organizations. Curr Heart Fail Rep. 2013 Sep 12;10(3):254–61. doi: 10.1007/s11897-013-0140-1.
    1. Crundall-Goode A, Goode KM, Clark AL. What impact do anxiety, depression, perceived control and technology capability have on whether patients with chronic heart failure take-up or continue to use home tele-monitoring services? Study design of ADaPT-HF. Eur J Cardiovasc Nurs. 2017 Apr 07;16(4):283–9. doi: 10.1177/1474515116657465.1474515116657465
    1. Eurlings CG, Boyne JJ, de Boer RA, Brunner-La Rocca HP. Telemedicine in heart failure-more than nice to have? Neth Heart J. 2019 Jan 10;27(1):5–15. doi: 10.1007/s12471-018-1202-5. 10.1007/s12471-018-1202-5
    1. Crundall-Goode A, Goode KM. Using telehealth for heart failure: barriers, pitfalls and nursing service models. Br J Card Nurs. 2014 Aug 02;9(8):396–406. doi: 10.12968/bjca.2014.9.8.396.
    1. Taylor J, Coates E, Brewster L, Mountain G, Wessels B, Hawley MS. Examining the use of telehealth in community nursing: identifying the factors affecting frontline staff acceptance and telehealth adoption. J Adv Nurs. 2015 Feb 29;71(2):326–37. doi: 10.1111/jan.12480.
    1. Mechanic O, Persaud Y, Kimball A. Telehealth systems. StatPearls. 2019. [2021-10-08]. .
    1. LeRouge C, Garfield M. Crossing the telemedicine chasm: have the U.S. barriers to widespread adoption of telemedicine been significantly reduced? Int J Environ Res Public Health. 2013 Nov 28;10(12):6472–84. doi: 10.3390/ijerph10126472. ijerph10126472
    1. Ware P, Dorai M, Ross HJ, Cafazzo JA, Laporte A, Boodoo C, Seto E. Patient adherence to a mobile phone-based heart failure telemonitoring program: a longitudinal mixed-methods study. JMIR Mhealth Uhealth. 2019 Feb 26;7(2):e13259. doi: 10.2196/13259. v7i2e13259

Source: PubMed

Sponzoři a spolupracovníci

Zdravotní podmínky

Drogové intervence

3
Předplatit